INVO Fertility, Inc. (IVF) is a Medical - Devices company in the Healthcare sector, currently trading at $2.18. It has a SharesGrow Score of 45/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is IVF = $4 (+83.5% upside).
Valuation: IVF trades at a trailing Price-to-Earnings (P/E) of -0.1 (S&P 500 average ~25).
Financials: revenue is $7M, +101.1%/yr average growth. Net income is $9M (loss), growing at -16.9%/yr. Net profit margin is -139.3% (negative). Gross margin is 44% (-52.5 pp trend).
Balance sheet: total debt is $10M against $13M equity (Debt-to-Equity (D/E) ratio 0.78, moderate). Current ratio is 0.07 (tight liquidity). Debt-to-assets is 21.3%. Total assets: $46M.
Analyst outlook: 1 / 1 analysts rate IVF as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 17/100 (Fail), Moat 28/100 (Fail), Future 100/100 (Pass), Income 10/100 (Fail).
